Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia

被引:96
|
作者
Shojaee, Seyedmehdi [1 ]
Caeser, Rebecca [1 ,14 ]
Buchner, Maike [1 ]
Park, Eugene [14 ]
Swaminathan, Srividya [1 ]
Hurtz, Christian [1 ]
Geng, Huimin [1 ]
Chan, Lai N. [1 ]
Klemm, Lars [1 ]
Hofmann, Wolf-Karsten [2 ]
Qiu, Yi Hua [3 ]
Zhang, Nianxiang [4 ]
Coombes, Kevin R. [4 ]
Paietta, Elisabeth [5 ]
Molkentin, Jeffery [6 ,7 ]
Koeffler, H. Phillip [8 ,9 ]
Willman, Cheryl L. [10 ]
Hunger, Stephen P. [11 ]
Melnick, Ari [12 ,13 ]
Kornblau, Steven M. [3 ]
Mueschen, Markus [1 ]
机构
[1] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA
[2] Heidelberg Univ, Med Fak Mannheim, Med Klin 3, D-68167 Heidelberg, Germany
[3] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA
[5] Albert Einstein Coll Med, Bronx, NY 10466 USA
[6] Univ Cincinnati, Howard Hughes Med Inst, Cincinnati, OH 45247 USA
[7] Univ Cincinnati, Cincinnati Childrens Hosp, Cincinnati, OH 45247 USA
[8] Cedars Sinai Med Ctr, Div Hematol & Oncol, Los Angeles, CA 90095 USA
[9] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore
[10] Univ New Mexico, Ctr Canc, Dept Pathol, Albuquerque, NM 87102 USA
[11] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA
[12] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA
[13] Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA
[14] Univ Cambridge, Dept Haematol, Cambridge CB2 0AH, England
关键词
KINASE; SPROUTY2; DUSP6; PROLIFERATION; INHIBITOR; MUTATIONS; PONATINIB; MOUSE; RAS; ABL;
D O I
10.1016/j.ccell.2015.05.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Studying mechanisms of malignant transformation of human pre-B cells, we found that acute activation of oncogenes induced immediate cell death in the vast majority of cells. Few surviving pre-B cell clones had acquired permissiveness to oncogenic signaling by strong activation of negative feedback regulation of Erk signaling. Studying negative feedback regulation of Erk in genetic experiments at three different levels, we found that Spry2, Dusp6, and Etv5 were essential for oncogenic transformation in mouse models for pre-B acute lymphoblastic leukemia (ALL). Interestingly, a small molecule inhibitor of DUSP6 selectively induced cell death in patient-derived pre-B ALL cells and overcame conventional mechanisms of drug-resistance.
引用
收藏
页码:114 / 128
页数:15
相关论文
共 50 条
  • [31] Mer receptor tyrosine kinase is a therapeutic target in pre-B-cell acute lymphoblastic leukemia
    Linger, Rachel M. A.
    Lee-Sherick, Alisa B.
    DeRyckere, Deborah
    Cohen, Rebecca A.
    Jacobsen, Kristen M.
    McGranahan, Amy
    Brandao, Luis N.
    Winges, Amanda
    Sawczyn, Kelly K.
    Liang, Xiayuan
    Keating, Amy K.
    Tan, Aik Choon
    Earp, H. Shelton
    Graham, Douglas K.
    BLOOD, 2013, 122 (09) : 1599 - 1609
  • [32] Drug Screening of Primary Human Pediatric Pre-B Cell Acute Lymphoblastic Leukemia (pre-B ALL) Cells in Their Stromal Niche
    Shieh, Jae-Hung
    Su, Tsann-Long
    Shieh, Jason
    Moore, Malcolm A. S.
    BLOOD, 2012, 120 (21)
  • [33] Characterization of mesenchymal stem cells in pre-B acute lymphoblastic leukemia
    Hughes, Anastasia M. M.
    Kuek, Vincent
    Oommen, Joyce
    Chua, Grace-Alyssa
    van Loenhout, Maria
    Malinge, Sebastien
    Kotecha, Rishi S. S.
    Cheung, Laurence C. C.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [34] PTEN opposes negative selection and enables oncogenic transformation of pre-B cells
    Seyedmehdi Shojaee
    Lai N Chan
    Maike Buchner
    Valeria Cazzaniga
    Kadriye Nehir Cosgun
    Huimin Geng
    Yi Hua Qiu
    Marcus Dühren von Minden
    Thomas Ernst
    Andreas Hochhaus
    Giovanni Cazzaniga
    Ari Melnick
    Steven M Kornblau
    Thomas G Graeber
    Hong Wu
    Hassan Jumaa
    Markus Müschen
    Nature Medicine, 2016, 22 : 379 - 387
  • [35] PTEN opposes negative selection and enables oncogenic transformation of pre-B cells
    Shojaee, Seyedmehdi
    Chan, Lai N.
    Buchner, Maike
    Cazzaniga, Valeria
    Cosgun, Kadriye Nehir
    Geng, Huimin
    Qiu, Yi Hua
    von Minden, Marcus Duehren
    Ernst, Thomas
    Hochhaus, Andreas
    Cazzaniga, Giovanni
    Melnick, Ari
    Kornblau, Steven M.
    Graeber, Thomas G.
    Wu, Hong
    Jumaa, Hassan
    Mueschen, Markus
    NATURE MEDICINE, 2016, 22 (04) : 379 - +
  • [36] The bone marrow microenvironment of pre-B acute lymphoblastic leukemia at single-cell resolution
    Denise Anderson
    Patrycja Skut
    Anastasia M. Hughes
    Emanuela Ferrari
    Jennifer Tickner
    Jiake Xu
    Benjamin H. Mullin
    Dave Tang
    Sébastien Malinge
    Ursula R. Kees
    Rishi S. Kotecha
    Timo Lassmann
    Laurence C. Cheung
    Scientific Reports, 10
  • [37] A distinct DNA methylation signature defines pediatric pre-B cell acute lymphoblastic leukemia
    Wong, Nicholas C.
    Ashley, David
    Chatterton, Zac
    Parkinson-Bates, Mandy
    Ng, Hong Kiat
    Halemba, Minhee S.
    Kowalczyk, Adam
    Bedo, Justin
    Wang, Qiao
    Bell, Katrina
    Algar, Elizabeth
    Craig, Jeffrey M.
    Saffery, Richard
    EPIGENETICS, 2012, 7 (06) : 535 - 541
  • [38] The bone marrow microenvironment of pre-B acute lymphoblastic leukemia at single-cell resolution
    Anderson, Denise
    Skut, Patrycja
    Hughes, Anastasia M.
    Ferrari, Emanuela
    Tickner, Jennifer
    Xu, Jiake
    Mullin, Benjamin H.
    Tang, Dave
    Malinge, Sebastien
    Kees, Ursula R.
    Kotecha, Rishi S.
    Lassmann, Timo
    Cheung, Laurence C.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [39] Rosai-Dorfman Disease in a Child with a History of Pre-B Cell Acute Lymphoblastic Leukemia
    Ramos, J. V.
    Razzaqi, F.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2025, 73 (01) : 359 - 360
  • [40] The BCR-ABL1 kinase bypasses selection for the expression of a pre-B cell receptor in pre-B acute lymphoblastic leukemia cells
    Klein, F
    Feldhahn, N
    Harder, L
    Wang, H
    Wartenberg, M
    Hofmann, WK
    Wernet, P
    Siebert, R
    Müschen, M
    JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (05): : 673 - 685